Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Exogenous female sex steroid hormones and new-onset asthma in women: a matched case–control study

Fig. 3

Ever use of menopausal hormone therapy (compared to never use) and new-onset asthma in menopausal women. a The results were from Frequentist conditional logistic regression. b Posterior probability distribution estimated from Bayesian conditional logistic regression, based on the original prior probability distribution \(\mathrm{log}OR\sim N(0.17,{0.13}^{2})\) for use of menopausal hormone therapy; the vertical bold line indicates the median of the posterior distribution, and the shaded area under the curve indicates the 95% central posterior interval. All analyses were conducted based on the multiply imputed datasets (\(m=\) 100), adjusted for age, place of residence, level of education, body mass index, tobacco smoking, environmental tobacco smoke, age at menopause, physical exercise and gynecological conditions. Abbreviations: CI, confidence interval; PI, posterior interval. Superscript lowercase letter a (a) indicates the following: age at baseline in 2008

Back to article page